New products are live, and we’ve lowered prices across the catalog. Free overnight shipping on orders over $200.

Metabolic Pens

Tirzepatide 50mg Pen

$320.00

Tirzepatide 2.5 mL Pen

The Science, Simplified: Tirzepatide is a synthetic peptide studied as a dual GIP/GLP-1 receptor agonist research tool.

Product Specifications – Tirzepatide 50 mg 2.5 mL Pen

  • Total Tirzepatide: 50 mg
  • Volume: 2.5 mL pre-filled pen
  • Clicks in the pen: 250
  • Volume per click: 0.01 mL
  • Dial range: 1–60 clicks per dispensing (0.01–0.60 mL)
  • Peptide per click: 200 mcg Tirzepatide
  • Concentration: 20 mg/mL
  • Purity: ≥99%, third-party tested (COA available)
  • Format: Ready-to-use multi-use pre-filled pen
  • Also available research strengths: 10 mg, 20 mg, 30 mg, 40 mg, 60 mg pens

Key Research Focus: Dual GIP and GLP-1 receptor research.

Physical Form & Solubility:

  • Appearance: Clear to slightly opalescent liquid
  • Solubility: Already in aqueous solution. Highly soluble; no reconstitution required.

Pen Format Details: The 2.5 mL pre-filled pen is a multi-use system designed for precise, consistent dispensing of the research compound. It features a sealed cartridge and dial mechanism for accurate volume control. The pen is ready for immediate laboratory use with no mixing or transfer steps required. Each pen is labeled with total peptide content and lot-specific COA reference.

Stability & Handling Notes:

  • Refrigerated at 2–8°C (36–46°F). Practical shelf life is 12–16 weeks when protected from light and handled with clean laboratory technique.
  • Do not freeze. Avoid prolonged room-temperature exposure.
  • Store upright in the original packaging with the cap on, and avoid temperature swings. Discard if the solution becomes cloudy, discolored, or shows particles.
  • Protect from light and moisture at all times.

Tirzepatide Research Studies

Selected English-language peer-reviewed references for laboratory research context. Links open publisher or PubMed/PMC records.

Read the Tirzepatide research overview

  1. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 DiabetesPubMed 34170647
  2. Tirzepatide Once Weekly for the Treatment of ObesityPubMed 35658024
  3. Tirzepatide for Obesity Treatment and Diabetes PreventionPubMed 39536238
  4. Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity ManagementPubMed 36750526
  5. Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development programPubMed 36478180
Tirzepatide amino acid chain
Tirzepatide — amino acid chain (N→C)